Inflammatory Lesion Macrophage Exit from a Peripheral 1 Integrin

Total Page:16

File Type:pdf, Size:1020Kb

Inflammatory Lesion Macrophage Exit from a Peripheral 1 Integrin Published March 18, 2013, doi:10.4049/jimmunol.1202097 The Journal of Immunology a1b1 Integrin-Mediated Adhesion Inhibits Macrophage Exit from a Peripheral Inflammatory Lesion Henry M. Becker,*,†,‡ Jacob Rullo,*,† Mian Chen,* Magar Ghazarian,* Sungho Bak,* Haiyan Xiao,* John B. Hay,‡ and Myron I. Cybulsky*,† Integrins are adhesion molecules critical for the recruitment of leukocytes from blood into peripheral tissues. However, whether integrins are also involved in leukocyte exit from peripheral tissues via afferent lymphatics to the draining lymph node remains poorly understood. In this article, we show that adhesion by the collagen IV–binding integrin a1b1 unexpectedly inhibited macrophage exit from inflamed skin. We monitored macrophages exiting mouse footpads using a newly developed in situ pulse labeling technique. Blockade of a1b1 integrin or genetic deletion (Itga12/2) increased macrophage exit efficiency. Chemotaxis assays through collagen IV showed more efficient migration of Itga12/2 macrophages relative to wild type. Given that macro- phages are key orchestrators of inflammation, a1b1 integrin adhesion may represent a mechanism for regulating inflammatory responses by controlling macrophage exit or persistence in inflamed tissues. The Journal of Immunology, 2013, 190: 000–000. he extent and duration of leukocyte accumulation at the The family of integrins associated with the b1 subunit (CD29) site of tissue inflammation can have a profound effect on includes several that bind ECM molecules, and some of these are T the course of inflammation, as well as on tissue injury. found on leukocytes, including macrophages (7). This b1 subset of Leukocyte accumulation in tissues is dependent on multiple factors integrins was first identified on T cells but appeared only after days including the rate of recruitment from the blood, active retention, or weeks of in vitro culture; hence they were named very late Ags apoptosis, and egress from tissues, resulting in migration to re- 1–6, and since that time, additional a subunits have been found that gional lymph nodes (LNs) via afferent lymphatics. Tissue entry of can associate with the b1 chain (7–10). Very late Ag 1 (a1b1 leukocyte subsets requires adhesion to the vascular endothelium integrin or CD49a/CD29) on T cells was the first of the b1 group to and is controlled by a well-described combinatorial cascade of be characterized, and it was found to bind ECM, in particular, events involving several families of molecules including integrins collagen IV, but not collagen I (11). Later studies further charac- (1, 2). Classic experiments have shown that the absence or terized a1b1 integrin expression on T cells, as well as confirming blockade of leukocyte integrins inhibits blood to tissue migration its ability to adhere to collagen IV (12–14). The a1b1 integrin was in both homeostatic and inflammatory conditions (1, 3, 4). Al- also shown to be important in inflammatory responses, required for though the importance of leukocyte integrins for blood-to-tissue T cell–mediated inflammation including delayed-type hypersensi- migration has been firmly established, their potential role in ex- tivity and resistance to viral infection (13, 15). More recently, data travascular tissues is still poorly understood. Some studies using have emerged demonstrating a critical role for a1b1 integrin in inflamed lymphatic endothelium in vitro have suggested that there macrophage activation showing that the binding of Semaphorin7A are integrin-dependent steps during T cell entry into afferent (Sema7A) expressed on T cells to a1b1 integrin expressed on mac- lymphatics (5). Other studies in mouse ear explants have found rophages is required for effective macrophage inflammatory cyto- integrins to be dispensable for dendritic cell migration and entry kine secretion (16). into afferent lymphatics (6). If integrins are important in extra- Current models hold that when leukocyte integrins bind their vascular leukocyte migration, then integrins that can bind extra- ligands, this facilitates cell migration. Therefore, integrins are cellular matrix (ECM) constituents would be a logical subset to generally viewed as adhesion molecules with a promigratory investigate. function. Whether integrin-mediated adhesion can also inhibit leukocyte migration is less clear. Intriguingly, data generated from integrin-deficient dendritic cells demonstrated normal migration *Toronto General Research Institute, University Health Network, Toronto, Ontario through noninflamed extravascular tissues (6). This suggests the M5G 2C4, Canada; †Department of Laboratory Medicine and Pathobiology, Univer- sity of Toronto, Toronto, Ontario M5G 1L7, Canada; and ‡Department of Immu- possibility that in the appropriate biological context, integrins nology, University of Toronto, Toronto, Ontario M5G 1L7, Canada might play an alternate adhesive role as “anchoring” molecules, Received for publication July 30, 2012. Accepted for publication February 14, 2013. inhibiting rather than facilitating leukocyte migration. We inves- This work was supported by the Canadian Institutes of Health Research (Operating tigated the function of a1b1 integrin in an inflammatory model Grant MOP-89740 to M.I.C.; Canadian Graduate Scholarship Doctoral Award to J.R.) using a newly developed in situ pulse labeling technique. Our and the Heart and Stroke Foundation of Ontario (Career Investigator Award to M.I.C.). results show that the collagen IV–binding integrin a1b1 inhibits Address correspondence and reprint requests to Dr. Henry M. Becker and Dr. Myron macrophage exit from a peripheral inflammatory lesion. Cybulsky, University of Toronto, 101 College Street, TMDT 3-303, Toronto, ON M5G 1L7, Canada,. E-mail addresses: [email protected] (H.M.B.) and [email protected] (M.C.) Materials and Methods The online version of this article contains supplemental material. Animals Abbreviations used in this article: ECM, extracellular matrix; EP, ethylpyridylated; 2/2 ISPL, in situ pulse labeling; LN, lymph node; Sema7A, Semaphorin7A; S1P, a1 integrin knockout mice (Itga1 ) bred onto a C57BL/6 background sphingosine-1 phosphate. for at least 12 generations were a gift from A. Pozzi. For experiments, C57BL/6 (Jackson Laboratories) and Itga12/2 mice were between 8 and Copyright Ó 2013 by The American Association of Immunologists, Inc. 0022-1767/13/$16.00 12 wk old. All animal experiments were approved by the University Health www.jimmunol.org/cgi/doi/10.4049/jimmunol.1202097 2 a1b1 INTEGRIN-MEDIATED ADHESION Network Animal Care Committee and performed according to institutional duced into the flow chamber and allowed to adhere for 5 min. Images of and federal guidelines. four high-powered fields were acquired by fluorescence microscopy; then ashearforceof10dynes/cm2 was applied for 1 min to induce cell de- Footpad injections and in situ pulse labeling tachment. After flow was stopped, images of four additional high- powered fields were obtained, and macrophages that remained adherent Con A (20 mgin20ml PBS; Sigma) was injected into mouse footpads using a 50-ml Hamilton syringe. The fluorescent dye CFSE (Invitrogen before and after shear were counted. Chemotactic migration assays were m Molecular Probes) was prepared according to the manufacturer’s instruc- performed in Corning Costar Transwell chambers with 5- Mmicropo- tions and further diluted in PBS to obtain a final concentration of 1.44 mM. rous membrane filters separating the upper and lower chambers. Mem- m Mice were lightly anesthetized using isoflurane via nosecone, and a tour- branes were coated overnight (4˚C) with collagen IV (2.5 g/ml), collagen I (1 mg/ml), laminin (10 mg/ml), or fatty acid–free BSA (10 mg/ niquet was applied at the distal calf. CFSE (10 ml) was injected into a Con ml; Sigma), then rinsed with PBS. ECM gel (Sigma; 10 mlusedundi- A–inflamed footpad using a 10-ml Hamilton syringe fitted with a custom- made 33-gauge needle. The tourniquet was removed 15 min after the luted, “neat”) was applied to membranes for 10 min (22˚C) and allowed CFSE injection, and mice were returned to cages. In some experiments, to polymerize (as per manufacturer’s instructions). Transwell experi- inflamed footpads were first injected with Ab (10 mg Ha31/8 or control Ab, ments were carried out at 37˚C in DMEM with 2 mg/ml fatty acid–free BSA and 1:100 Penicillin V/Streptomycin (Wisent). Two-hundred micro- Armenian Hamster IgG2, l1, both NA/LE; BD Pharmingen), Obtustatin 2 2 Itga1+/+ Itga1 / (10 mg; a gift from C. Marcinkiewicz), or pertussis toxin (List Bio- liters total of differentially labeled and macrophages or Con A exudates in approximately equal proportions (5 3 106 cells/ml) chemicals). After 3 min, a tourniquet was applied and in situ pulse labeling were introduced into the upper chamber. The lower chamber contained (ISPL) was performed. CCL21 (10 nM; PeproTech). Macrophages were allowed to chemotac- Cell isolation tically migrate through the coated membranes for 18 h, at which point the cells that had migrated to the lower chamber were isolated, immu- Single-cell suspensions were prepared from mouse footpads and popliteal nostained as required, and analyzed by flow cytometry. Data from each LNs. In both cases and regardless of treatment, cells excluded propidium in vitro assay were normalized to the ratio of Itga1+/+ and Itga12/2 input iodide and there was no difference between Itga1+/+ and Itga12/2 staining. macrophages. For isolation of cells from the footpad, mice were euthanized by carbon dioxide or isofluorane overdose and perfused with ice-cold PBS via the left Histology, cytospins, and cell sorting ventricle. Footpad tissue (∼8 by 4 mm) was excised from the plantar surface, cut into small squares (,1 mm), and digested (1 h, 37˚C) with Footpads were excised and fixed for at least 24 h in 10% buffered formalin. Liberase CI (250 mg/ml; Roche) and DNase I (50 mg/ml; Roche) in In some experiments, footpads were decalcified using HCl/EDTA before m DMEM (Sigma). EDTA (10 mM final concentration) was then added and embedding in paraffin, sectioning (5 or 2 m), and staining with H&E. For samples were incubated on ice for 5 min.
Recommended publications
  • Innate Pro–B-Cell Progenitors Protect Against Type 1 Diabetes By
    Innate pro–B-cell progenitors protect against type 1 PNAS PLUS diabetes by regulating autoimmune effector T cells Ruddy Montandona,b,1, Sarantis Korniotisa,b,1, Esther Layseca-Espinosaa,b,2, Christophe Grasa,b, Jérôme Mégretc, Sophie Ezinea,d, Michel Dya,b, and Flora Zavalaa,b,3 aFaculté de Médecine Site Necker, Université Paris Descartes, bCentre National de la Recherche Scientifique Unité Mixte de Recherche 8147, 75015 Paris, France; cInstitut Fédératif de Recherche 94 Necker-Enfants Malades, 75015 Paris, France; and dInstitut National de la Santé et de la Recherche Médicale U1020, 75015 Paris, France Edited by Simon Fillatreau, Deutsches Rheuma-Forschungszentrum, Berlin, Germany, and accepted by the Editorial Board May 6, 2013 (received for review December 24, 2012) Diverse hematopoietic progenitors, including myeloid populations emergence of regulatory B cells (Bregs), along with acquired-type arising in inflammatory and tumoral conditions and multipotent stimulation, such as B-cell receptor (BCR) engagement concomi- cells, mobilized by hematopoietic growth factors or emerging during tant or not with CD40 activation (10, 11). Such induced regulatory parasitic infections, display tolerogenic properties. Innate immune B-cell functions are believed to be more robust than those ex- stimuli confer regulatory functions to various mature B-cell subsets pressed by naive and resting B cells, which can nevertheless tolerize but immature B-cell progenitors endowed with suppressive proper- naive T cells and induce regulatory T cells (Tregs) (12, 13). ties per se or after differentiating into more mature regulatory Bregs are a heterogeneous lymphocyte subset present among all B cells remain to be characterized. Herein we provide evidence for major B-cell populations (14–17).
    [Show full text]
  • 2021 Undergraduate Research Symposium Program
    FORDHAM COLLEGE AT ROSE HILL 14TH ANNUAL UNDERGRADUATE RESEARCH SYMPOSIUM Wednesday, May 5, 2021 AN INTERDISCIPLINARY CELEBRATION OF OUR STUDENTS AND MENTORS The Fourteenth Annual Fordham College at Rose Hill Undergraduate Research Symposium Program | Spring 2021 Welcome to the Fourteenth Annual FCRH Research Symposium, for the first time in a hybrid format! The accomplishments of our students and mentors during the pandemic have been extraordinary and we are overjoyed to celebrate them today. From our beautiful campus, to their homes throughout the country and beyond, our undergraduate research community was always open for new discoveries. We are delighted to share 120 abstracts from over 200 students who pursued their projects during such challenging times. Their work, dedication, and determination to be a part of today’s event is inspiring and what FCRH undergraduate research is all about. We are in this together to urge each other on and findings shared today may well change the world. We are also proud to announce that the 11th volume of the Fordham Undergraduate Research Journal has been published. The FURJ team took on an enormous undertaking of running their operation in hybrid format, with a record number of submissions, and as always, they have dazzled us with the quality of their efforts. Undergraduate research has become a part of who we are at FCRH. Because of this, our program, against all odds in the past year, continues to grow, expanding across disciplines and accessible to all students in a number of ways. Students are creating new knowledge in our labs, independently with the guidance of their mentors, as part of innovative class projects, and even to support their activism.
    [Show full text]
  • Human Hypoxanthine (Guanine) Phosphoribosyltransferase: An
    Proc. NatL Acad. Sci. USA Vol. 80, pp. 870-873, Febriary 1983 Medical Sciences Human hypoxanthine (guanine) phosphoribosyltransferase: An amino acid substitution in a mutant form of the enzyme isolated from a patient with gout (reverse-phase HPLC/peptide mapping/mutant enzyme) JAMES M. WILSON*t, GEORGE E. TARRt, AND WILLIAM N. KELLEY*t Departments of *Internal Medicine and tBiological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109 Communicated by James B. Wyngaarden, November 3, 1982 ABSTRACT We have investigated the molecular basis for a tration ofenzyme protein. in both erythrocytes (3) and lympho- deficiency ofthe enzyme hypoxanthine (guanine) phosphoribosyl- blasts (4); (ii) a normal Vm., a normal Km for 5-phosphoribosyl- transferase (HPRT; IMP:pyrophosphate-phosphoribosyltransfer- 1-pyrophosphate, and a 5-fold increased Km for hypoxanthine ase, EC 2.4.2.8) in a patient with a severe form of gout. We re-. (unpublished data); (iii) a normal isoelectric point (3, 4) and ported in previous studies the isolation of a unique structural migration during nondenaturing polyacrylamide gel electro- variant of HPRT from this patient's erythrocytes and cultured phoresis (4); and (iv) -an apparently smaller subunit molecular lymphoblasts. This enzyme variant, which is called HPRTOnd0., weight as evidenced by an increased mobility during Na- is characterized by a decreased concentration of HPRT protein DodSO4/polyacrylamide gel electrophoresis (3, 4). in erythrocytes and lymphoblasts, a normal Vm.., a 5-fold in- Our study ofthe tryptic peptides and amino acid composition creased Km for hypoxanthine, a normal isoelectric point, and an of apparently smaller subunit molecular weight. Comparative pep- HPRTLondon revealed a single amino acid substitution (Ser tide mapping-experiments revealed a single abnormal tryptic pep- Leu) at position 109.
    [Show full text]
  • Studies on the Mechanism of Action of 6-Mercaptopurine in Sensitive and Resistant L1210 Leukemia in Vitro*
    Studies on the Mechanism of Action of 6-Mercaptopurine in Sensitive and Resistant L1210 Leukemia in Vitro* JACKD. DAVIDSON (Clinical Pharmacology and Experimental Tlierapeutics Service, National Cancer Institute, Betliesda, Md.) SUMMARY A study was made of the effects of 6-mercaptopurine (6-MP) upon nucleic acid metabolism in L1210 leukemia cells in vitro. Pharmacological concentrations of 6-MP inhibited the incorporation of both hypoxanthine and glycine into adenine nucleo- tides. Higher concentrations of 6-MP inhibited the incorporation of hypoxanthine into both adenine and guanine nucleotides. In a subline of L1210 which is resistant to 6-MP there was much less utilization of hypoxanthine than in the sensitive line, and incorporation into both adenine and guanine moieties was strongly inhibited by 6-MP. On the contrary, utilization of glycine for nucleotide purine synthesis was unaffected by 6-MP. These findings support the hypothesis that in L1210 leukemia 6-MP is metabolized to its ribotide, and this produces a metabolic block in the conversion of inosinic acid to adenylic acid. They further indicate that, in the L1210 cells resistant to 6-MP, there is a very limited capacity to convert 6-MP and hypoxanthine to ribotides. This leads to competition between 6-MP and hypoxanthine and to formation of insufficient 6-MP ribotide to cause the critical block. Although 6-mercaptopurine (6-MP) has been purines isolated from L1210 ascites leukemia cells studied with respect to its antitumor activity since have been studied. The results obtained suggest 1952, there is still relatively little information re that the primary antimetabolic activity of 6-MP garding the mechanism of its action.
    [Show full text]
  • Anti-Cd49a / Integrin Alpha 1 Antibody (ARG57529)
    Product datasheet [email protected] ARG57529 Package: 50 μg anti-CD49a / Integrin alpha 1 antibody Store at: -20°C Summary Product Description Goat Polyclonal antibody recognizes CD49a / Integrin alpha 1 Tested Reactivity Hu Tested Application WB Host Goat Clonality Polyclonal Isotype IgG Target Name CD49a / Integrin alpha 1 Antigen Species Human Immunogen Synthetic peptide around the internal region of Human CD49a / Integrin alpha 1. (C-DKHDFQDSVRIT) Conjugation Un-conjugated Alternate Names VLA-1; CD49a; Integrin alpha-1; Laminin and collagen receptor; VLA1; CD antigen CD49a; CD49 antigen- like family member A Application Instructions Application table Application Dilution WB 0.3 - 1 µg/ml Application Note WB: Recommend incubate at RT for 1h. * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Calculated Mw 131 kDa (NP_852478.1) Observed Size 150 kDa (glycosylated form) Properties Form Liquid Purification Ammonium sulphate precipitation followed by affinity purification with immunogen. Buffer Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA. Preservative 0.02% Sodium azide Stabilizer 0.5% BSA Concentration 0.5 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/2 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol ITGA1 Gene Full Name integrin, alpha 1 Background This gene encodes the alpha 1 subunit of integrin receptors.
    [Show full text]
  • Laminin-Binding Integrin A7,1: Functional Characterization and Expression in Normal and Malignant Melanocytes
    CELL REGULATION, Vol. 2, 805-817, October 1991 Laminin-binding integrin a7,1: functional characterization and expression in normal and malignant melanocytes Randall H. Kramer,*t$ Mai P. Vu,* increased attachment to laminin exhibit much Yao-Fen Cheng,* Daniel M. Ramos,* higher metastatic potential in lung colonization Rupert Timpl,§ and Nahid Waleh 11 assays (reviewed in Liotta et aL, 1986). Fur- *Departments of Stomatology and Anatomy thermore, the presence of intact laminin will en- and the tCardiovascular Research Institute hance lung colonization (Barsky et aL., 1984). University of California These results and others strongly suggest that San Francisco, California 94143 melanoma cells interact with laminin-rich base- §Max-Planck-lnstitut fur Biochemie ment membrane and that this interaction facil- Martinsried, Germany itates their vascular arrest and colonization of IISRI International distant sites. Menlo Park, California 94025 During tissue invasion, metastatic melanoma cells interact with different types of extracellular matrix, including the interstitium and basement A novel integrin, a,#,, that specifically binds with membranes. It is expected, then, that these high affinity to laminin has been identified on mel- malignant cells will express surface adhesion anoma cells. This complex was purified from both receptors with diverse ligand specificities human and murine melanoma cells by laminin-af- (Ruoslahti and Giancotti, 1989). The integrin finity chromatography, and the a7 subunit was re- family of adhesion receptors consists of a large covered after gel electrophoresis. N-terminal amino number of heterodimer receptors that appear acid sequence analysis of the a7 subunit from both to mediate many of the cell-extracellular matrix human and mouse cells verifies that this integrin interactions for melanoma and other cell types is distinct from other a chains in the #I family, al- (Hynes, 1987; Ruoslahti and Pierschbacher, though strikingly similar to the as subunit.
    [Show full text]
  • Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency
    Arch Dis Child: first published as 10.1136/adc.62.4.385 on 1 April 1987. Downloaded from Archives of Disease in Childhood, 1987, 62, 385-391 Central nervous system dysfunction and erythrocyte guanosine triphosphate depletion in purine nucleoside phosphorylase deficiency H A SIMMONDS, L D FAIRBANKS, G S MORRIS, G MORGAN, A R WATSON, P TIMMS, AND B SINGH Purine Laboratory, Guy's Hospital, London, Department of Immunology, Institute of Child Health, London, Department of Paediatrics, City Hospital, Nottingham, Department of Paediatrics and Chemical Pathology, National Guard King Khalid Hospital, Jeddah, Saudi Arabia SUMMARY Developmental retardation was a prominent clinical feature in six infants from three kindreds deficient in the enzyme purine nucleoside phosphorylase (PNP) and was present before development of T cell immunodeficiency. Guanosine triphosphate (GTP) depletion was noted in the erythrocytes of all surviving homozygotes and was of equivalent magnitude to that found in the Lesch-Nyhan syndrome (complete hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency). The similarity between the neurological complications in both disorders that the two major clinical consequences of complete PNP deficiency have differing indicates copyright. aetiologies: (1) neurological effects resulting from deficiency of the PNP enzyme products, which are the substrates for HGPRT, leading to functional deficiency of this enzyme. (2) immunodeficiency caused by accumulation of the PNP enzyme substrates, one of which, deoxyguanosine, is toxic to T cells. These studies show the need to consider PNP deficiency (suggested by the finding of hypouricaemia) in patients with neurological dysfunction, as well as in T cell immunodeficiency. http://adc.bmj.com/ They suggest an important role for GTP in normal central nervous system function.
    [Show full text]
  • Xanthine/Hypoxanthine Assay Kit
    Product Manual Xanthine/Hypoxanthine Assay Kit Catalog Number MET-5150 100 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Xanthine and hypoxanthine are naturally occurring purine derivatives. Xanthine is created from guanine by guanine deaminase, from hypoxanthine by xanthine oxidoreductase, and from xanthosine by purine nucleoside phosphorylase. Xanthine is used as a building block for human and animal drug medications, and is an ingredient in pesticides. In vitro, xanthine and related derivatives act as competitive nonselective phosphodiesterase inhibitors, raising intracellular cAMP, activating Protein Kinase A (PKA), inhibiting tumor necrosis factor alpha (TNF-α) as well as and leukotriene synthesis. Furthermore, xanthines can reduce levels of inflammation and act as nonselective adenosine receptor antagonists. Hypoxanthine is sometimes found in nucleic acids such as in the anticodon of tRNA in the form of its nucleoside inosine. Hypoxanthine is a necessary part of certain cell, bacteria, and parasitic cultures as a substrate and source of nitrogen. For example, hypoxanthine is often a necessary component in malaria parasite cultures, since Plasmodium falciparum needs hypoxanthine to make nucleic acids as well as to support energy metabolism. Recently NASA studies with meteorites found on Earth supported the idea that hypoxanthine and related organic molecules can be formed extraterrestrially. Hypoxanthine can form as a spontaneous deamination product of adenine. Because of its similar structure to guanine, the resulting hypoxanthine base can lead to an error in DNA transcription/replication, as it base pairs with cytosine. Hypoxanthine is typically removed from DNA by base excision repair and is initiated by N- methylpurine glycosylase (MPG).
    [Show full text]
  • Mechanism of Excessive Purine Biosynthesis in Hypoxanthine- Guanine Phosphoribosyltransferase Deficiency
    Mechanism of excessive purine biosynthesis in hypoxanthine- guanine phosphoribosyltransferase deficiency Leif B. Sorensen J Clin Invest. 1970;49(5):968-978. https://doi.org/10.1172/JCI106316. Research Article Certain gouty subjects with excessive de novo purine synthesis are deficient in hypoxanthineguanine phosphoribosyltransferase (HG-PRTase [EC 2.4.2.8]). The mechanism of accelerated uric acid formation in these patients was explored by measuring the incorporation of glycine-14C into various urinary purine bases of normal and enzyme-deficient subjects during treatment with the xanthine oxidase inhibitor, allopurinol. In the presence of normal HG-PRTase activity, allopurinol reduced purine biosynthesis as demonstrated by diminished excretion of total urinary purine or by reduction of glycine-14C incorporation into hypoxanthine, xanthine, and uric acid to less than one-half of control values. A boy with the Lesch-Nyhan syndrome was resistant to this effect of allopurinol while a patient with 12.5% of normal enzyme activity had an equivocal response. Three patients with normal HG-PRTase activity had a mean molar ratio of hypoxanthine to xanthine in the urine of 0.28, whereas two subjects who were deficient in HG-PRTase had reversal of this ratio (1.01 and 1.04). The patterns of 14C-labeling observed in HG-PRTase deficiency reflected the role of hypoxanthine as precursor of xanthine. The data indicate that excessive uric acid in HG-PRTase deficiency is derived from hypoxanthine which is insufficiently reutilized and, as a consequence thereof, catabolized inordinately to uric acid. The data provide evidence for cyclic interconversion of adenine and hypoxanthine derivatives. Cleavage of inosinic acid to hypoxanthine via inosine does […] Find the latest version: https://jci.me/106316/pdf Mechanism of Excessive Purine Biosynthesis in Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency LEIF B.
    [Show full text]
  • Xj 128 IUMP Glucose Substance Will Be Provisionally Referred to As UDPX (Fig
    426 Studies on Uridine-Diphosphate-Glucose By A. C. PALADINI AND L. F. LELOIR Instituto de Inve8tigacione&s Bioquimicas, Fundacion Campomar, J. Alvarez 1719, Buenos Aires, Argentina (Received 18 September 1951) A previous paper (Caputto, Leloir, Cardini & found that the substance supposed to be uridine-2'- Paladini, 1950) reported the isolation of the co- phosphate was uridine-5'-phosphate. The hydrolysis enzyme of the galactose -1- phosphate --glucose - 1 - product of UDPG has now been compared with a phosphate transformation, and presented a tenta- synthetic specimen of uridine-5'-phosphate. Both tive structure for the substance. This paper deals substances were found to be identical as judged by with: (a) studies by paper chromatography of puri- chromatographic behaviour (Fig. 1) and by the rate fied preparations of uridine-diphosphate-glucose (UDPG); (b) the identification of uridine-5'-phos- 12A UDPG phate as a product of hydrolysis; (c) studies on the ~~~~~~~~~~~~~(a) alkaline degradation of UDPG, and (d) a substance similar to UDPG which will be referred to as UDPX. UMP Adenosine UDPG preparation8 8tudied by chromatography. 0 UjDPX Paper chromatography with appropriate solvents 0 has shown that some of the purest preparations of UDP UDPG which had been obtained previously contain two other compounds, uridinemonophosphate 0 4 (UMP) and a substance which appears to have the same constitution as UDPG except that it contains an unidentified component instead of glucose. This Xj 128 IUMP Glucose substance will be provisionally referred to as UDPX (Fig. la). The three components have been tested for co- enzymic activity in the galactose-1-phosphate-- 0-4 -J UDPX glucose-l-phosphate transformation, and it has been confirmed that UDPG is the active substance.
    [Show full text]
  • Availability and Quality of Published Data on the Purine Content of Foods, ⋆ T Alcoholic Beverages, and Dietary Supplements ⁎ Beiwen Wua, , Janet M
    Journal of Food Composition and Analysis 84 (2019) 103281 Contents lists available at ScienceDirect Journal of Food Composition and Analysis journal homepage: www.elsevier.com/locate/jfca Study Review Availability and quality of published data on the purine content of foods, ⋆ T alcoholic beverages, and dietary supplements ⁎ Beiwen Wua, , Janet M. Roselandb, David B. Haytowitzb,1, Pamela R. Pehrssonb, Abby G. Ershowc a Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA b Methods and Application of Food Composition Laboratory, Agricultural Research Service, US Department of Agriculture, Beltsville, MD 20705, USA c Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA ARTICLE INFO ABSTRACT Keywords: Gout, the most common type of inflammatory arthritis and associated with elevated uric acid levels, is aglobal Purine burden. “Western” dietary habits and lifestyle, and the resulting obesity epidemic, are often blamed for the Adenine increased prevalence of gout. Purine intake has shown the biggest dietary impact on uric acid. To manage this Guanine situation, data on the purine content of foods are needed. To assess availability and quality of purine data and Hypoxanthine identify research gaps, we obtained data for four purine bases (adenine, guanine, hypoxanthine, and xanthine) in Xanthine foods, alcoholic beverages, and dietary supplements. Data were predominantly from Japan, and very little from Gout Hyperuricemia the United States. Data quality was examined using a modified version of the USDA Data Quality Evaluation Food analysis System. Purine values in 298 foods/19 food groups, 15 alcoholic beverages, and 13 dietary supplements were Food composition reported. Mean hypoxanthine (mg/100 g) in the soups/sauces group was 112 and mean adenine in poultry Data quality organs was 62.4, which were the highest among all groups.
    [Show full text]
  • Developmental Disorder Associated with Increased Cellular Nucleotidase Activity (Purine-Pyrimidine Metabolism͞uridine͞brain Diseases)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 11601–11606, October 1997 Medical Sciences Developmental disorder associated with increased cellular nucleotidase activity (purine-pyrimidine metabolismyuridineybrain diseases) THEODORE PAGE*†,ALICE YU‡,JOHN FONTANESI‡, AND WILLIAM L. NYHAN‡ Departments of *Neurosciences and ‡Pediatrics, University of California at San Diego, La Jolla, CA 92093 Communicated by J. Edwin Seegmiller, University of California at San Diego, La Jolla, CA, August 7, 1997 (received for review June 26, 1997) ABSTRACT Four unrelated patients are described with a represent defects of purine metabolism, although no specific syndrome that included developmental delay, seizures, ataxia, enzyme abnormality has been identified in these cases (6). In recurrent infections, severe language deficit, and an unusual none of these disorders has it been possible to delineate the behavioral phenotype characterized by hyperactivity, short mechanism through which the enzyme deficiency produces the attention span, and poor social interaction. These manifesta- neurological or behavioral abnormalities. Therapeutic strate- tions appeared within the first few years of life. Each patient gies designed to treat the behavioral and neurological abnor- displayed abnormalities on EEG. No unusual metabolites were malities of these disorders by replacing the supposed deficient found in plasma or urine, and metabolic testing was normal metabolites have not been successful in any case. except for persistent hypouricosuria. Investigation of purine This report describes four unrelated patients in whom and pyrimidine metabolism in cultured fibroblasts derived developmental delay, seizures, ataxia, recurrent infections, from these patients showed normal incorporation of purine speech deficit, and an unusual behavioral phenotype were bases into nucleotides but decreased incorporation of uridine.
    [Show full text]